Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
We can't afford to be half hearted about vaccination programmes
| The first 150 words of the full text of this article appear below. |
The goal of a rubella vaccine programme is to reduce the occurrence of the congenital rubella syndrome. In this week's BMJ, Panagiotopoulos et al describe the history of the use of rubella vaccine in Greece and show that partial vaccine coverage led to a period in which susceptibility to rubella among childbearing women was actually increased (p 1462).1 Therefore in 1993, an epidemic year for rubella in Greece, the incidence of rubella in childbearing women was higher than in previous epidemics, and the incidence of congenital rubella increased. What lessons can we learn from this failure?
Around the world the effectiveness of rubella vaccine programmes has
varied. The rubella vaccine, which was first introduced in the United
States in 1967, was very effective in reducing the annual number of
babies with congenital rubella syndrome from an estimated 20 000 in
1964 to 7 in 1983.2 The US had introduced the vaccine in
Read all Rapid Responses